ArticleOdontology2026
Effects of Photobiomodulation and MTA on SHED cell viability and differentiation: an in vitro comparative study.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mineral trioxide aggregate (MTA) is commonly used to manage immature teeth with necrotic pulps due to its biological activity and favorable sealing properties. However, stem cell responses to MTA vary depending on exposure conditions. Photobiomodulation (PBM) has been proposed as a non-invasive modality that may enhance stem cell viability and differentiation. This study aimed to compare the effects of MTA, PBM, and their combination on the viability and differentiation potential of stem cells from human exfoliated deciduous teeth (SHED). SHED were assigned to four groups: control, MTA, PBM, and MTA + PBM. PBM was delivered using an 890 nm diode laser in continuous-wave, non-contact mode, with irradiation times adjusted according to plate format. For the MTT assay, cells were exposed to 25% NeoPUTTY MTA extract, whereas in the osteogenic differentiation experiments, MTA extracts were added to SHED cultured in osteogenic medium. Cell viability was assessed by MTT assay on Days 1, 3, and 7. Osteogenic differentiation was evaluated by Alizarin Red S staining after 14 days, and quantitative real-time PCR was performed to assess the expression of alkaline phosphatase (ALP), osteocalcin (OC), dentin sialophosphoprotein (DSPP), cementum protein 1 (CEMP1), and interleukin-1 beta (IL-1β). In the MTT assay, the PBM group showed the highest viability at Days 1, 3, and 7, whereas the MTA group showed the lowest viability, with the greatest reduction observed on Day 3. The MTA + PBM group showed higher viability than MTA alone at Days 3 and 7. In the Alizarin Red S assay, PBM showed the highest mineral deposition, followed by MTA + PBM, osteogenic medium alone, MTA, and control. qRT-PCR showed the highest expression of ALP, OC, DSPP, and CEMP1 in the PBM group, while IL-1β expression was highest in the MTA group. The combination group showed intermediate values between PBM and MTA for most outcomes. Within the limitations of this in vitro study, PBM showed the most favorable overall biological response in SHED, and the addition of PBM improved the response observed with MTA alone.
Indexed as
Identifiers
42322502What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.